Evaluation of two commercial enzyme immunoassays for the diagnosis ofHelicobacter pylori infection

Authors:

Abstract
Sera from 65 patients with upper gastrointestinal tract symptoms and provenHelicobacter pylori infection, and from 42 negative controls were tested with two commercial EIAs (GAP test, Bio-Rad; and ECP test, Biometra) and two non-commercial EIAs, one performed with whole sonicated cells and the other with acid extract ofHelicobacter pylori as antigen. The GAP assay showed a sensitivity of 83.1 % and a specificity of 47.6 %. The ECP assay showed a sensitivity of 87.7 % and a specificity of 61.9 %. For both non-commercial EIAs these figures were 87.7 % and 88.1 %, respectively. Independent of the interpretive criteria established by the manufacturers, receiver operating characteristic curves were plotted for better evaluation of the four methods. Both commercial tests showed a lower probability of yielding a correct diagnosis than the non-commercial tests (p Helicobacter pylori infection, the accuracy of the two commercial tests evaluated in this study was lower compared to that of the two non-commercial EIAs.

This publication has 16 references indexed in Scilit: